Ascendis Pharma AS (ASND) - Pharmaceuticals & Healthcare - Deals and Alliances Profile.

Summary

Ascendis Pharma A/S (Ascendis) is a biopharmaceutical company that offers drug discovery and development services. The companys pipeline products include transcon growth hormone, transcon PTH, transcon CNP, transcon treprostinil, transcon ranibizumab and transcon peptides. Its transcon ranibizumab is used for the treatment of age related macular edema and other ophthalmic indications. Ascendis conducts research and develops new drug candidates for treatment. The companys products are used in the therapeutic areas of diabetes, growth hormone deficiency, endocrinology, pulmonary arterial hypertension and others. It partners with pharmaceutical and biotechnology companies to develop new products. The company has its research and development facilities in Germany and Denmark. Ascendis is headquartered in Hellerup, Denmark.

Ascendis Pharma AS (ASND) - Pharmaceuticals & Healthcare - Deals and Alliances Profile. provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

2
List of Tables 3
List of Figures 4
Ascendis Pharma A/S, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Ascendis Pharma A/S, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Ascendis Pharma A/S, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Ascendis Pharma A/S, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Ascendis Pharma A/S, Medical Devices Deals, 2011 to YTD 2017 10
Ascendis Pharma A/S, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Ascendis Pharma A/S, Pharmaceuticals & Healthcare, Deal Details 12
Venture Financing 12
Ascendis Pharma Raises USD60 Million in Series D Venture Financing 12
Partnerships 13
Ascendis Pharma Enters Into Collaboration Agreement with Genentech 13
Equity Offering 14
Ascendis Pharma Plans to Raise up to USD400 Million in Public Offering of Shares 14
Ascendis Pharma Raises USD120 Million in Public Offering of ADS 15
Ascendis Pharma Raises USD124 Million in IPO 16
Ascendis Pharma A/S - Key Competitors 19
Key Employees 20
Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Recent Developments 22
Financial Announcements 22
May 23, 2017: Ascendis Pharma Reports First Quarter 2017 Financial Results 22
Mar 22, 2017: Ascendis Pharma Reports Full Year 2016 Financial Results 23
Nov 30, 2016: Ascendis Pharma Reports Third Quarter 2016 Financial Results 24
Aug 31, 2016: Ascendis Pharma Reports Second Quarter 2016 Financial Results and Provides Business Update 25
May 19, 2016: Ascendis Pharma Reports First Quarter 2016 Financial Results 26
Apr 14, 2016: Ascendis Pharma Reports Full Year 2015 Financial Results 27
Corporate Communications 29
Aug 08, 2016: Ascendis Pharma Appoints Scott T. Smith as Chief Financial Officer 29
Clinical Trials 30
Apr 04, 2016: Ascendis Pharma Announces TransCon Growth Hormone Oral and Poster Presentations at ENDO 2016 30
Appendix 31
Methodology 31
About GlobalData 31
Contact Us 31
Disclaimer 31

List Of Tables


Ascendis Pharma A/S, Pharmaceuticals & Healthcare, Key Facts, 2016 1
Ascendis Pharma A/S, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Ascendis Pharma A/S, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Ascendis Pharma A/S, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Ascendis Pharma A/S, Deals By Therapy Area, 2011 to YTD 2017 8
Ascendis Pharma A/S, Medical Devices Deals, 2011 to YTD 2017 10
Ascendis Pharma A/S, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Ascendis Pharma Raises USD60 Million in Series D Venture Financing 12
Ascendis Pharma Enters Into Collaboration Agreement with Genentech 13
Ascendis Pharma Plans to Raise up to USD400 Million in Public Offering of Shares 14
Ascendis Pharma Raises USD120 Million in Public Offering of ADS 15
Ascendis Pharma Raises USD124 Million in IPO 16
Ascendis Pharma A/S, Key Competitors 19
Ascendis Pharma A/S, Key Employees 20
Ascendis Pharma A/S, Subsidiaries 21

List Of Figures


Ascendis Pharma A/S, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1
Ascendis Pharma A/S, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1
Ascendis Pharma A/S, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1
Ascendis Pharma A/S, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1
Ascendis Pharma A/S, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Ascendis Pharma A/S, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6
Ascendis Pharma A/S, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Ascendis Pharma A/S, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Ascendis Pharma A/S, Medical Devices Deals, 2011 to YTD 2017 10

Ascendis Pharma AS (ASND) - Financial and Strategic SWOT Analysis Review

Ascendis Pharma AS (Ascendis Pharma) is a biopharmaceutical company that focuses on developing drugs for endocrinology and oncology indications. It is investigating TransCon hGH, a long-acting human growth hormone prodrug

USD 300 View Report

Ascendis Pharma A/S (ASND) - Financial and Strategic SWOT Analysis Review

Ascendis Pharma A/S (ASND) - Financial and Strategic SWOT Analysis Review

USD 300 View Report

Ascendis Pharma AS (ASND) - Financial and Strategic SWOT Analysis Review

Ascendis Pharma AS (Ascendis Pharma) is a biopharmaceutical company that focuses on developing drugs for endocrinology and oncology indications. It is investigating TransCon hGH, a long-acting human growth hormone prodrug

USD 300 View Report

Leo Pharma AS - Strategic SWOT Analysis Review

Leo Pharma AS - Strategic SWOT Analysis Review market research report available in single user pdf license with Aarkstore Enterprise at USD 125

USD 125 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available